Making Scientists Move Faster

We provide tools and technologies that streamline workflows
– from scientific discoveries to new medicines

Featured

  • Genovis Acquires KPL

    We are expanding our enzyme platform with a proprietary portfolio of precision proteases for protein analysis

  • Digested Guide to ASMS

    In this year’s Digested Guide to ASMS, we’ve gathered selected presentations and posters we’re especially excited to follow. We hope the guide helps you discover inspiring science and plan your ASMS schedule!

About Genovis

We offer customers in the biopharmaceutical and research industries tools that facilitate and save time in the development of new treatment methods and diagnostics.

Our enzyme products, SmartEnzymes, are a unique selection of rapid and easy-to-use enzymatic tools designed to improve the efficacy and throughput in analytical or preparative workflows for complex biopharmaceuticals. The enzymes are used by scientists all over the world and the innovative product formats facilitate the characterization, development, production, and quality control of biological drugs.

More About Genovis

Applications

Our products support a wide range of applications across biopharma, biotechnology, academic research, and genomics – helping scientists gain deeper insight into their molecules and products.

From enzyme solutions for protein characterization and glycan analysis to tools for bioconjugation, glycan remodeling, and nucleic acid workflows, our technologies are designed to support key analytical and development processes – particularly in mass spectrometry. Across both protein and genomic applications, we help simplify complex workflows, improve data quality, and enable more comprehensive characterization of biological systems.

Explore our applications to see how our solutions can support your research and development.

Explore Applications

News

Genovis Acquires KPL

2026-06-01

We are expanding our enzyme platform with a proprietary portfolio of precision proteases for protein analysis! We have entered into an agreement to acquire, and completed the acquisition of, 100 percent of the shares in KPL ApS (“KPL”), a Denmark‑based life science tools company with a proprietary portfolio of precision enzymes (proteases), both commercialized and…

More blog posts

Latest Video/Webinar

GlyCLICK® in Action: uPAR-Directed ADC Case Study

2026-05-25

Genoviswebinars - GlyCLICK® in Action: A Versatile Platform for Antibody Conjugation – Preclinical Case Study of uPAR-Directed ADCs

More Videos

Events

All Events